title: Modulation of hematopoietic stem/progenitor cell engraftment by transforming growth factor beta.
abstract: OBJECTIVE
  To investigate if cell cycle progression plays a role in modulating the engraftment potential of mouse hematopoietic stem and progenitor cells (HSPC).
  
  
  METHODS
  HSPC were isolated from adult mouse bone marrow, cultured in vitro under conditions promoting cell cycle arrest, and subsequently were evaluated for cell cycle status, clonogenic activity, and transplant potential. RESULTS In the presence of steel factor (STL) as a survival cytokine, transforming growth factor beta (TGF-beta) increased the G0/G1 fraction of cycling progenitor cells (Rh(high)) after a 20-hour culture. Clonogenic activity of quiescent long-term repopulating (Rh(low)) HSPC was unaffected by this culture, whereas clonogenic potential of Rh(high) cells decreased by about 30%. In competitive repopulation assays, Rh(low) cells cultured in STL + TGF-beta engrafted better than cells cultured in STL alone. However, culture in STL + TGF-beta did not overcome the failure of Rh(high) cells to engraft after transplant. We also utilized a two-stage culture system to first induce proliferation of Rh(low) HSPC by a 48-hour culture in STL + interleukin 6 + Flt-3 ligand, followed by shifting the culture to STL + TGF-beta for 24 hours to induce cycle arrest. A competitive repopulation assay demonstrated a relative decrease in repopulating potential in cultures that were cycle arrested compared to those that were not.
  
  
  CONCLUSIONS
  Cell cycle progression by itself cannot account for the decrease in repopulating potential that is observed after ex vivo expansion. Other determinants of engraftment must be identified to facilitate the transplantation of cultured HSPC.
authors.affiliation: Department of Oncological Sciences, University of Utah, Salt Lake City 84132, USA.
authors.forename: A
authors.initials: A
authors.lastname: Wiesmann
authors.forename: M
authors.initials: M
authors.lastname: Kim
authors.forename: A
authors.initials: A
authors.lastname: Georgelas
authors.forename: A E
authors.initials: AE
authors.lastname: Searles
authors.forename: D D
authors.initials: DD
authors.lastname: Cooper
authors.forename: W F
authors.initials: WF
authors.lastname: Green
authors.forename: G J
authors.initials: GJ
authors.lastname: Spangrude
mesh_terms: D000818:Animals; D001772:Blood Cell Count; D002453:Cell Cycle / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D006085:Graft Survival / Q000187:drug effects; D019650:Hematopoietic Stem Cell Mobilization; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000473:pathology*; D051379:Mice; D008810:Mice, Inbred C57BL; D016212:Transforming Growth Factor beta / Q000494:pharmacology*
chemical_list: D016212:Transforming Growth Factor beta